1998
DOI: 10.1006/bbrc.1998.9444
|View full text |Cite
|
Sign up to set email alerts
|

Stimulation of Mitogenesis by a Cell-Permeable PI 3-Kinase Binding Peptide

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
46
0

Year Published

2001
2001
2017
2017

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 64 publications
(49 citation statements)
references
References 25 publications
3
46
0
Order By: Relevance
“…In the present study, using a peptide mimetic of the pTyr domain of the PDGF receptor to increase PI3K activation (Derossi et al, 1998), we show that PI3K activation induces synaptogenic and spinogenic effects on primary cultures of rat hippocampal neurons and also on CA1 hippocampal neurons in vivo. Furthermore, these morphological changes are functional according to the criteria of increased basal neurotransmitter release, and correlate with an enhancement of cognitive behavior in the treated animals.…”
Section: Introductionmentioning
confidence: 53%
“…In the present study, using a peptide mimetic of the pTyr domain of the PDGF receptor to increase PI3K activation (Derossi et al, 1998), we show that PI3K activation induces synaptogenic and spinogenic effects on primary cultures of rat hippocampal neurons and also on CA1 hippocampal neurons in vivo. Furthermore, these morphological changes are functional according to the criteria of increased basal neurotransmitter release, and correlate with an enhancement of cognitive behavior in the treated animals.…”
Section: Introductionmentioning
confidence: 53%
“…Because of difficulty in performing gene therapy in human, we activated dormant follicles using a PTEN inhibitor and a PI3K activator based on a short-term (2 days) in vitro activation protocol. Previous studies showed that a PTEN inhibitor, bpV, indirectly activates the PI3K-AKT signaling pathway (Posner et al 1994, Bavan et al 1995, Schmid et al 2004, whereas a cell-permeable phosphopeptide, 740Y-P, binds to the SH2 domain of p85 regulatory subunit of PI3K to activate its catalytic subunit (Derossi et al 1998). Using both drugs, we demonstrated that short-term culture of neonatal mouse and human ovaries increased primary follicle numbers via nuclear exclusion of FOXO3 in vitro (Li et al 2010).…”
Section: Development Of New Therapy For Poi Based On Pi3k-akt Signalingmentioning
confidence: 68%
“…Ovaries containing mainly primordial follicles were obtained from neonatal mice at day 3 of age. Pairs of ovaries were incubated with bpV(pic) (100 μM) or culture media (control group) for 24 h. In addition to bpV(pic), some ovaries were treated for 48 h with a cell-permeable phospho-peptide (740Y-P) capable of binding to the SH2 domain of the p85 regulatory subunit of PI3K to stimulate enzyme activity (10). Activated PI3K converts phosphatidylinositol (4, 5)-bisphosphate (PIP2) to phosphatidylinositol (3-5)-trisphosphate (PIP3), whereas the PTEN inhibitor prevents the conversion of PIP3 back to PIP2.…”
Section: Resultsmentioning
confidence: 99%
“…The synthetic 740Y-P peptide has a phosphorylated tyrosine residue with flanking sequences identical to the interaction site of activated PDGF receptor, together with a protein transduction domain (16 residues) of the fly Antennapedia protein (25) to facilitate plasma membrane penetration. Peptide 740Y-P is a potent stimulator of PI3K activity and mitogenic responses in myoblast cells (10) and promotes primordial germ cell migration by mimicking the action of the receptor tyrosine kinase c-kit (26). This PI3K-activating peptide likely increases intracellular PIP3 levels, mimicking the effects of ovarian ligands for tyrosine kinase receptors such as kit ligand, PDGF, leukemia inhibitor factor, and neurotrophins (17)(18)(19)27).…”
Section: Discussionmentioning
confidence: 99%